Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Publication Year: 2024

Authors & Co-authors:  Landovitz Raphael J RJ Tao Li L Yang Juan J de Boer Melanie M Carter Christoph C Das Moupali M Baeten Jared M JM Liu Albert A Hoover Karen W KW Celum Connie C

High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women.

Journal: PloS one

Publication Year: 2017

Authors & Co-authors:  Carballo-Diéguez Alex A Balán Ivan C IC Brown William W Giguere Rebecca R Dolezal Curtis C Leu Cheng-Shiun CS Marzinke Mark A MA Hendrix Craig W CW Piper Jeanna M JM Richardson Barbra A BA

Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

Journal: AIDS and behavior

Publication Year: 2018

Authors & Co-authors:  Carballo-Diéguez Alex A Giguere Rebecca R Dolezal Curtis C Leu Cheng-Shiun CS Balán Iván C IC Brown William W Rael Christine C Richardson Barbra A BA Piper Jeanna M JM Bekker Linda-Gail LG